By Josh White
Date: Wednesday 04 Jun 2025
LONDON (ShareCast) - (Sharecast News) - Abingdon Health announced on Wednesday that it has deepened its strategic relationship with US-based diagnostics firm Find Out From Home (FOFH), appointing company president Chris Yates as a director of FOFH.
The AIM-listed rapid test developer and manufacturer holds a 19% stake in FOFH through a service-for-equity arrangement, and was supporting the US company's product development and regulatory efforts.
Abingdon and FOFH are currently working on gaining regulatory approval for four self-test kits targeting sexually transmitted diseases, under a $2m contract announced in December.
In addition, the two companies were collaborating on the development of a further three STD tests.
At 1030 BST, shares in Abingdon Health were down 2.43% at 6.83p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 6.42p |
Change Today | 0.17p |
% Change | 2.67 % |
52 Week High | 9.00p |
52 Week Low | 5.25p |
Volume | 73,569 |
Shares Issued | 193.63m |
Market Cap | £12.42m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:51 | 10,000 @ 6.38p |
15:43 | 627 @ 6.38p |
15:28 | 58,055 @ 6.15p |
14:04 | 1,952 @ 6.13p |
12:43 | 1,358 @ 6.15p |
You are here: research